Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Total Current Liabilities (2021 - 2025)

Historic Total Current Liabilities for Coeptis Therapeutics Holdings (COEPW) over the last 5 years, with Q3 2025 value amounting to $2.7 million.

  • Coeptis Therapeutics Holdings' Total Current Liabilities fell 2136.17% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 2136.17%. This contributed to the annual value of $4.5 million for FY2024, which is 5101.26% up from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Total Current Liabilities of $2.7 million as of Q3 2025, which was down 2136.17% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Total Current Liabilities registered a high of $5.7 million during Q1 2025, and its lowest value of $31816.0 during Q1 2021.
  • Over the past 5 years, Coeptis Therapeutics Holdings' median Total Current Liabilities value was $2.6 million (recorded in 2023), while the average stood at $2.4 million.
  • Data for Coeptis Therapeutics Holdings' Total Current Liabilities shows a peak YoY increase of 397604.53% (in 2022) and a maximum YoY decrease of 2142.2% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Coeptis Therapeutics Holdings' Total Current Liabilities stood at $2.8 million in 2021, then decreased by 21.42% to $2.2 million in 2022, then surged by 37.56% to $3.0 million in 2023, then soared by 51.01% to $4.5 million in 2024, then crashed by 40.06% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $4.5 million for Q2 2025, and $5.7 million during Q1 2025.